Evidence map›Paper›PMID 37689591›Full record

ArticleJournal of neurology2024

Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP).

Astrid Van den Broecke, Alexander Decruyenaere, Nika Schuermans, Hannah Verdin, Jody Ghijsels, Anne Sieben, Bart Dermaut, Dimitri Hemelsoet

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Genetic Creutzfeldt-Jakob disease associated with 5-octapeptide repeat insertion in the PRNP gene: case and pedigree report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Update on Genetic Chorea.European journal of neurology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Astrid Van den BroeckeDepartment of Neurology, Ghent University Hospital, Ghent, Belgium. astrid.vandenbroecke@uzgent.be.ORCID http://orcid.org/0000-0003-4084-6855
Alexander DecruyenaereDepartment of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Nika SchuermansCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Hannah VerdinCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Jody GhijselsCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Anne SiebenBorn-Bunge Institute, Laboratory for Neuropathology, University of Antwerp, Antwerp, Belgium.
Bart DermautCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Dimitri HemelsoetDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Ghent University Hospital · BEUniversity of Antwerp · BE

Funding

Bijzonder Onderzoeksfonds UGent 01N10319Fonds Wetenschappelijk Onderzoek 3G0H8318
6 · The paper itself

Abstract

Inherited prion diseases caused by two- to twelve-octapeptide repeat insertions (OPRIs) in the prion protein gene (PRNP) show significant clinical heterogeneity. This study describes a family with two new cases with a 4-OPRI mutation and two asymptomatic mutation carriers. The pooled analysis summarizes all cases reported in the literature to date and describes the relation between survival, age of onset, number of OPRI and codon 129 polymorphism. MEDLINE and Google Scholar were queried from database inception up to December 31, 2022. Age of onset was compared per number of OPRI and per codon 129 polymorphism using the Kruskal-Wallis and Wilcoxon-Mann-Whitney tests, respectively. Disease duration was modeled non-parametrically by a Kaplan-Meier model and semi-parametrically by a Cox model. This study comprised 164 patients. Lower number of OPRI and presence of valine (cis-V) versus methionine (cis-M) on codon 129 were associated with an older age of onset (P < 0.001 and P = 0.025, respectively) and shorter disease duration (P < 0.001 and P = 0.003, respectively). Within patients with 5- or more OPRI codon cis-V remained significantly associated with a shorter disease duration. Codon 129 homozygosity versus heterozygosity was not significantly associated with age of onset or disease duration (P = 0.076 and P = 0.409, respectively). This study summarized the largest cohort of patients with two- to twelve-OPRI to date. Lower number of OPRI and codon 129 cis-V is associated with an older age of onset and shorter disease duration, while homozygosity or heterozygosity on codon 129 was not.

Indexed as

Creutzfeldt-Jakob SyndromePrion DiseasesPrionsCodonHumansMutationPrion ProteinsCodonPrion ProteinsPrionsPRNP protein, humanCreutzfeldt–Jakob diseaseGeneticsGerstmann–Sträussler–Scheinker syndromeOctapeptide repeat insertionPrion disease

Identifiers

PMID37689591
OpenAlexW4386578745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.